These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 27660262)

  • 1. Serum Markers of Neurodegeneration in Maple Syrup Urine Disease.
    Scaini G; Tonon T; de Souza CFM; Schuk PF; Ferreira GC; Neto JS; Amorin T; Schwartz IVD; Streck EL
    Mol Neurobiol; 2017 Sep; 54(7):5709-5719. PubMed ID: 27660262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-Carnitine supplementation decreases DNA damage in treated MSUD patients.
    Mescka CP; Guerreiro G; Hammerschmidt T; Faverzani J; de Moura Coelho D; Mandredini V; Wayhs CA; Wajner M; Dutra-Filho CS; Vargas CR
    Mutat Res; 2015 May; 775():43-7. PubMed ID: 25867118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular administration of α-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats.
    Wisniewski MS; Carvalho-Silva M; Gomes LM; Zapelini HG; Schuck PF; Ferreira GC; Scaini G; Streck EL
    Metab Brain Dis; 2016 Apr; 31(2):377-83. PubMed ID: 26586008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
    Amaral AU; Wajner M
    Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of dynamic thiol/disulphide homeostasis as a novel indicator of oxidative stress in maple syrup urine disease patients under treatment.
    Zubarioglu T; Kiykim E; Cansever MS; Neselioglu S; Aktuglu-Zeybek C; Erel O
    Metab Brain Dis; 2017 Feb; 32(1):179-184. PubMed ID: 27535382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
    Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
    Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease.
    Barschak AG; Sitta A; Deon M; de Oliveira MH; Haeser A; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):279-86. PubMed ID: 17091400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profile and peripheral markers of neurodegeneration in patients with Niemann-Pick type C: Decrease in Plasminogen Activator Inhibitor type 1 and Platelet-Derived Growth Factor type AA.
    Hammerschmidt TG; Encarnação M; Lamberty Faverzani J; de Fátima Lopes F; Poswar de Oliveira F; Fischinger Moura de Sousa C; Ribeiro I; Alves S; Giugliani R; Regla Vargas C
    Arch Biochem Biophys; 2023 Feb; 735():109510. PubMed ID: 36608914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
    Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model.
    Scaini G; Comim CM; Oliveira GM; Pasquali MA; Quevedo J; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Bogo MR; Streck EL
    J Inherit Metab Dis; 2013 Sep; 36(5):721-30. PubMed ID: 23109061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
    Xu J; Jakher Y; Ahrens-Nicklas RC
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
    Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
    Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
    Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
    Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
    J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary biomarkers of oxidative damage in Maple syrup urine disease: the L-carnitine role.
    Guerreiro G; Mescka CP; Sitta A; Donida B; Marchetti D; Hammerschmidt T; Faverzani J; Coelho Dde M; Wajner M; Dutra-Filho CS; Vargas CR
    Int J Dev Neurosci; 2015 May; 42():10-4. PubMed ID: 25680940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of murine models of classic and intermediate maple syrup urine disease.
    Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS
    BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease.
    Bridi R; Araldi J; Sgarbi MB; Testa CG; Durigon K; Wajner M; Dutra-Filho CS
    Int J Dev Neurosci; 2003 Oct; 21(6):327-32. PubMed ID: 12927581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease.
    Wessler LB; Ise K; Lemos IC; Rezende VL; Duarte MB; Damiani AP; de Oliveira J; de Andrade VM; Streck EL
    Metab Brain Dis; 2020 Aug; 35(6):905-914. PubMed ID: 32297169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
    Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
    Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eleven novel mutations of the BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease in the Chinese population: Report on eight cases.
    Li X; Ding Y; Liu Y; Ma Y; Song J; Wang Q; Li M; Qin Y; Yang Y
    Eur J Med Genet; 2015 Nov; 58(11):617-23. PubMed ID: 26453840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.